BACKGROUND: Two clinical risk scores, the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores, have been proposed to predict the risk of intracerebral haemorrhage following thrombolysis in acute ischaemic stroke. AIMS: To validate Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores as predictors of post-tissue plasminogen activator symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage in an independent cohort. METHODS: Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were calculated for the cohort of tissue plasminogen activator-treated patients enrolled in the placebo arms of the SAINT-I and SAINT-II trials. The absolute risk of symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage associated with each scoring system was determined. The overall predictive value was assessed using c-statistics. RESULTS: Symptomatic intracerebral haemorrhage occurred in 5.6% of 965 patients treated with tissue plasminogen activator in the SAINT cohorts. The risk of symptomatic intracerebral haemorrhage was modestly greater, with higher Haemorrhage After Thrombolysis scores (0: 4.1%, 1: 4.1%, 2: 8.8%, 3: 12.5%, 4: 0%, 5: no subjects). Similar results were seen with the Multicentre Stroke Survey score (0: 0%, 1: 4.8%, 2: 2.3%, 3: 7.3%, 4: 6.3%). In logistic regression, the Haemorrhage After Thrombolysis score was associated with the risk of symptomatic intracerebral haemorrhage (odds ratio = 1.41 per point, 95% confidence interval: 1.05-1.89, P = 0.021) and asymptomatic intracerebral haemorrhage (odds ratio = 1.59 per point, 95% confidence interval: 1.33-1.92, P< 0.001). The Multicentre Stroke Survey score was modestly associated with the risk of symptomatic intracerebral haemorrhage (odds ratio = 1.43 per point, 95% confidence interval: 0.95-2.15, P = 0.084) and asymptomatic intracerebral haemorrhage (odds ratio = 1.63 per point, 95% confidence interval: 1.27-2.08, P < 0.001). The c-statistic was 0.59 for predicting symptomatic intracerebral haemorrhage and 0.61 for asymptomatic intracerebral haemorrhage for both the Haemorrhage After Thrombolysis and the Multicentre Stroke Survey scores. CONCLUSIONS: While both the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were associated with a risk of symptomatic intracerebral haemorrhage, discriminatory ability was limited.
BACKGROUND: Two clinical risk scores, the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores, have been proposed to predict the risk of intracerebral haemorrhage following thrombolysis in acute ischaemic stroke. AIMS: To validate Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores as predictors of post-tissue plasminogen activator symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage in an independent cohort. METHODS:Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were calculated for the cohort of tissue plasminogen activator-treated patients enrolled in the placebo arms of the SAINT-I and SAINT-II trials. The absolute risk of symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage associated with each scoring system was determined. The overall predictive value was assessed using c-statistics. RESULTS: Symptomatic intracerebral haemorrhage occurred in 5.6% of 965 patients treated with tissue plasminogen activator in the SAINT cohorts. The risk of symptomatic intracerebral haemorrhage was modestly greater, with higher Haemorrhage After Thrombolysis scores (0: 4.1%, 1: 4.1%, 2: 8.8%, 3: 12.5%, 4: 0%, 5: no subjects). Similar results were seen with the Multicentre Stroke Survey score (0: 0%, 1: 4.8%, 2: 2.3%, 3: 7.3%, 4: 6.3%). In logistic regression, the Haemorrhage After Thrombolysis score was associated with the risk of symptomatic intracerebral haemorrhage (odds ratio = 1.41 per point, 95% confidence interval: 1.05-1.89, P = 0.021) and asymptomatic intracerebral haemorrhage (odds ratio = 1.59 per point, 95% confidence interval: 1.33-1.92, P< 0.001). The Multicentre Stroke Survey score was modestly associated with the risk of symptomatic intracerebral haemorrhage (odds ratio = 1.43 per point, 95% confidence interval: 0.95-2.15, P = 0.084) and asymptomatic intracerebral haemorrhage (odds ratio = 1.63 per point, 95% confidence interval: 1.27-2.08, P < 0.001). The c-statistic was 0.59 for predicting symptomatic intracerebral haemorrhage and 0.61 for asymptomatic intracerebral haemorrhage for both the Haemorrhage After Thrombolysis and the Multicentre Stroke Survey scores. CONCLUSIONS: While both the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were associated with a risk of symptomatic intracerebral haemorrhage, discriminatory ability was limited.
Authors: Joshua A Stone; Joshua Z Willey; Salah Keyrouz; James Butera; Ryan A McTaggart; Shawna Cutting; Brian Silver; Bradford Thompson; Karen L Furie; Shadi Yaghi Journal: Curr Treat Options Neurol Date: 2017-01 Impact factor: 3.598
Authors: William J Meurer; Heemun Kwok; Lesli E Skolarus; Eric E Adelman; Allison M Kade; Jack Kalbfleisch; Shirley M Frederiksen; Phillip A Scott Journal: Acad Emerg Med Date: 2013-02 Impact factor: 3.451
Authors: David Asuzu; Karin Nystrom; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210